Medication prescription in HF and CKD
Datasets
-
Variables
-
Aims to determine if patients hospitalized with HF (heart failure) and CKD (chronic kidney disease) are less likely to receive guideline-recommended medical therapy, and whether it is this associated with worse outcomes. Objectives:
- Differences in evidence-based HF medication prescription between subgroups
- Association between guideline-recommended levels vs. lower levels and outcomes between subgroups
- Personalized guideline-based medication prescription recommendation for all subgroups
- Start Year
- 2015
- End Year
- 2023
Design
- Study design
- Cohort
- Follow Up
- The study follows hospitalized patients with HF and CKD over time to assess their medication prescription patterns and subsequent outcomes.
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 4,563
- Number of participants with biosamples
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |
Availability of access information
By contacting the study representative
Sector of research
| Data | Biosamples | |
|---|---|---|
| Investigators from the public sector | ||
| Investigators from the private sector | ||
| Investigators from not-for-profit organization |
Transfer
| Data | Biosamples | |
|---|---|---|
| Can leave the study facility | ||
| Can leave the country |
Timeline
Baseline Population
Descrition of test population S1
Selection Criteria
- Minimum age
-
20
- Maximum age
-
70
- Newborns
- Twins
- Ethnic Origin
-
- Health Status
-
- Heart Failure Diagnosis
Recruitment
- Sources of recruitment
-
- Specific population
- Specific Population
-
- Clinic patients
Number of participants
- Number of participants
- 4,563 (No Limit)
- Number of participants with biosamples
- No Limit
Data Collection Event
- Start Date
-
2023
- End Date
-
2024
- Data sources
-
- Physical measures